GENI SCHEDULE 13G/A: SEC filing

Glenview Capital Management and Larry Robbins

Filed with the SEC on · accession 0000905148-26-004932

GENI filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -4.5% by the first close after the filing.

Summary of the filing

Glenview Capital Management and Larry Robbins filed an amended Schedule 13G reporting beneficial ownership of 16,620,590 ordinary shares, or approximately 6.2%, of Genius Sports Ltd as of September 30, 2026.

Key details

Beneficial ownership of ordinary shares$16.6M
Percentage of shares outstanding beneficially ownedPCT 6
Total shares outstanding as of September 30, 2026$267.9M
IssuerGenius Sports Ltd
Reporting person / investment managerGlenview Capital Management, LLC
Account holding 6,027,270 sharesGlenview Capital Master Fund, Ltd.
Account holding 10,222,174 sharesGlenview Offshore Opportunity Master Fund, Ltd.
Chief investment officer of glenview capital managementLarry Robbins
President of glenview capital managementMark J. Horowitz

How GENI stock reacted

Close before

$6.26

Nov 13, 2026

First close after

-4.47%

$5.98

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GENI, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GENI?

Click here

Frequently asked questions

What did GENI file with the SEC on Nov 16, 2026?

GENI filed a SCHEDULE 13G/A (SEC filing). Glenview Capital Management and Larry Robbins filed an amended Schedule 13G reporting beneficial ownership of 16,620,590 ordinary shares, or approximately 6.2%, of Genius Sports Ltd as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did GENI stock react to this filing?

GENI closed at $6.26 before the filing and $5.98 on Nov 16, 2026 (-4.47%).

Other GENI SEC filings

Get alerts when GENI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days